NLRP3 and type 1 diabetes mellitus: The NLRP3 inflammasome has consistently been shown to participate in the pathogenesis of many autoimmune disorders, including MS (multiple sclerosis), EAE (experimental autoimmune encephalomyelitis), IBD (inflammatory bowel disease) and T1DM (97–100).